Filing Details

Accession Number:
0001209191-22-008983
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-11 18:09:59
Reporting Period:
2022-02-09
Accepted Time:
2022-02-11 18:09:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1595893 Turning Point Therapeutics Inc. TPTX Pharmaceutical Preparations (2834) 463826166
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1758838 John Andrew Partridge 10628 Science Center Drive
San Diego CA 92121
Evp & Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-02-09 221 $36.30 22,078 No 4 S Direct
Common Stock Acquisiton 2022-02-09 16,283 $0.00 38,361 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2022-02-09 58,600 $0.00 58,600 $37.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
58,600 2032-02-08 No 4 A Direct
Footnotes
  1. Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to Reporting Person on February 8, 2021.
  2. The Reporting Person acquired 199 shares on June 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan (the "ESPP") and 333 shares on December 10, 2021 pursuant to the ESPP.
  3. Represents restricted stock unit award granted under the Issuer's 2019 Equity Plan.
  4. 1/48th of the shares vest monthly following February 9, 2022.